Journal of Neurovirology

Papers
(The median citation count of Journal of Neurovirology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19113
Persistent COVID-19-associated neurocognitive symptoms in non-hospitalized patients100
Opsoclonus-myoclonus syndrome, a post-infectious neurologic complication of COVID-19: case series and review of literature46
Chronic fatigue syndrome: an emerging sequela in COVID-19 survivors?43
Cognitive dysfunction following COVID-19 infection37
A case report of simultaneous autoimmune and COVID-19 encephalitis30
Optic neuritis following SARS-CoV-2 infection29
Magnetic resonance imaging features of COVID-19-related cranial nerve lesions29
Potential mechanisms of cerebrovascular diseases in COVID-19 patients27
Meningoencephalitis associated with COVID-19: a systematic review26
Acute transverse myelitis after SARS-CoV-2 infection: a rare complicated case of rapid onset paraplegia25
Neurological features and outcome in COVID-19: dementia can predict severe disease24
Neurological disease caused by Oropouche virus in northern Brazil: should it be included in the scope of clinical neurological diseases?21
Viruses, SUMO, and immunity: the interplay between viruses and the host SUMOylation system18
Collateral damage: Impact of SARS-CoV-2 pandemic in people living with HIV18
Chronically elevated depressive symptoms interact with acute increases in inflammation to predict worse neurocognition among people with HIV17
Human microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses16
Neuropathies and neurological dysfunction induced by coronaviruses16
Neuroinvasive potential of human coronavirus OC43: case report of fatal encephalitis in an immunocompromised host15
MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis?15
A case of trigeminal neuralgia developing after a COVID-19 vaccination15
iPSC-derived three-dimensional brain organoid models and neurotropic viral infections15
“Anosmia” the mysterious collateral damage of COVID-1914
HIV-1C and HIV-1B Tat protein polymorphism in Southern Brazil14
Association between high proviral load, cognitive impairment, and white matter brain lesions in HTLV-1-infected individuals14
The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation13
A wide spectrum of neurological manifestations in pediatrics patients with the COVID-19 infection: a case series13
A comprehensive review of COVID-19 biology, diagnostics, therapeutics, and disease impacting the central nervous system13
Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study13
Accelerated epigenetic aging in adolescents living with HIV is associated with altered development of brain structures13
Murine-β-coronavirus-induced neuropathogenesis sheds light on CNS pathobiology of SARS-CoV212
COVID-19-associated necrotizing encephalopathy presenting without active respiratory symptoms: a case report with histopathology12
Low levels of frailty in HIV-positive older adults on antiretroviral therapy in northern Tanzania12
Autonomic neuropathy as post-acute sequela of SARS-CoV-2 infection: a case report11
Machine learning prediction of neurocognitive impairment among people with HIV using clinical and multimodal magnetic resonance imaging data11
Guillain-Barré syndrome associated with COVID-19: a case report study11
Brain-derived neurotrophic factor (BDNF) is associated with depressive symptoms in older adults with HIV disease11
Clinical and magnetic resonance imaging patterns of extensive Chikungunya virus–associated myelitis11
Opsoclonus myoclonus ataxia syndrome in severe acute respiratory syndrome coronavirus-210
Coronavirus disease (COVID-19) complicated by rhino-orbital-cerebral mucormycosis presenting with neurovascular thrombosis: a case report and review of literature10
A human-derived 3D brain organoid model to study JC virus infection10
Cytomegalovirus infection induces Alzheimer’s disease-associated alterations in tau10
Molecular epidemiology of enteroviruses and predominance of echovirus 30 in an Iranian population with aseptic meningitis10
The increased intrathecal expression of the monocyte-attracting chemokines CCL7 and CXCL12 in tick-borne encephalitis9
Cerebral vasculitis caused by Talaromyces marneffei and Aspergillus niger in a HIV-positive patient: a case report and literature review9
HIV-1 Tat drives the Fabp4/NF-κB feedback loop in microglia to mediate inflammatory response and neuronal apoptosis9
Higher cerebrospinal fluid biomarkers of neuronal injury in HIV-associated neurocognitive impairment9
CD8+ T cells in the central nervous system of mice with herpes simplex infection are highly activated and express high levels of CCR5 and CXCR39
The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro8
Psychometric utility of the international HIV dementia scale and Montreal Cognitive Assessment in HIV-associated asymptomatic neurocognitive impairment8
Compassionate-use pocapavir and immunoglobulin therapy for treatment of rituximab-associated enterovirus meningoencephalitis8
TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use8
Monitoring of HTLV-1-associated diseases by proviral load quantification using multiplex real-time PCR8
Neurological manifestations of COVID-19: with emphasis on Iranian patients7
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disorders7
Viral protein R polymorphisms in the pathogenesis of HIV-associated acute ischaemic stroke: a case–control study7
The evaluation expression of non-coding RNAs in response to HSV-G47∆ oncolytic virus infection in glioblastoma multiforme cancer stem cells7
Hypoactivation in the precuneus and posterior cingulate cortex during ambiguous decision making in individuals with HIV7
Identification of dysregulated pathways underlying HTLV-1-associated myelopathy/tropical spastic paraparesis through co-expression network analysis7
Infection of human microglial cell line CHME-3 to study neuropathogenesis of chikungunya virus7
Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers7
Central nervous system vasculopathy associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a novel case report from Iran7
Detection of SARS-coronavirus-2 in the central nervous system of patients with severe acute respiratory syndrome and seizures7
Endolysosome iron restricts Tat-mediated HIV-1 LTR transactivation by increasing HIV-1 Tat oligomerization and β-catenin expression6
Multiple demyelinating sensory and motor mononeuropathy associated with COVID-19: a case report6
Revisiting JC virus and progressive multifocal leukoencephalopathy6
Limbic encephalitis in a COVID-19 patient?6
The association between benzodiazepine use and greater risk of neurocognitive impairment is moderated by medical burden in people with HIV6
Gut microbiota dysbiosis is associated with worse emotional states in HIV infection6
Pembrolizumab treatment of inflammatory progressive multifocal leukoencephalopathy: a report of two cases6
Mild encephalitis/encephalopathy with a reversible splenial lesion associated with respiratory syncytial virus infection in infants6
Unexpected worsening of progressive multifocal leucoencephalopathy following COVID-19 pneumonia6
Progressive multifocal leukoencephalopathy and Creutzfeldt-Jakob disease: population-wide incidences, comorbidities, costs of care, and outcomes6
Neuroimaging and immunological features of neurocognitive function related to substance use in people with HIV6
Brain tissue transcriptomic analysis of SIV-infected macaques identifies several altered metabolic pathways linked to neuropathogenesis and poly (ADP-ribose) polymerases (PARPs) as potential therapeut6
Illuminating the in vitro effects of Epstein-Barr virus and vitamin D on immune response in multiple sclerosis patients6
Pain, psychoaffective symptoms, and quality of life in human T cell lymphotropic virus type 1 (HTLV-1): a cross-sectional study6
Herpes simplex encephalitis in patients receiving chemotherapy and whole-brain radiation therapy6
Rates of cognitive impairment in a South African cohort of people with HIV: variation by definitional criteria and lack of association with neuroimaging biomarkers6
Brain damage serum biomarkers induced by COVID-19 in patients from northeast Brazil6
Effects of combination antiretroviral drugs (cART) on hippocampal neuroplasticity in female mice5
The impacts of HIV infection, age, and education on functional brain networks in adults with HIV5
Tryptophan depletion predicts lower positive affect in sexual minority men living with HIV who use methamphetamine5
HIV-1 subtype C Tat exon-1 amino acid residue 24K is a signature for neurocognitive impairment5
Human immunodeficiency virus-1 Tat exerts its neurotoxic effects by downregulating Sonic hedgehog signaling5
Susac syndrome complicating a SARS-CoV-2 infection5
Delayed post-hypoxic leukoencephalopathy in an adult with COVID-195
Chronic SSRI treatment reverses HIV-1 protein-mediated synaptodendritic damage5
Covid-19 post-infectious acute transverse myelitis responsive to corticosteroid therapy: report of two clinical cases5
Progressive multifocal leukoencephalopathy and peripheral neuropathy in a patient with Good’s syndrome5
CSF markers of AD-related pathology relate specifically to memory impairment in older people with HIV: a pilot study5
Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesis5
Cognitive performance in a South African cohort of people with HIV and comorbid major depressive disorder5
Combined effects of loneliness and inflammation on depression in people with HIV4
Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab4
Cerebrospinal fluid levels of 5-HIAA and dopamine in people with HIV and depression4
The relationship between vascular endothelial growth factor (VEGF) and amnestic mild cognitive impairment among older adults living with HIV4
Herpes zoster preceding neuromyelitis optica spectrum disorder: casual or causal relationship? A systematic literature review4
Rabies virus glycoprotein enhances spatial memory via the PDZ binding motif4
Amebic infections of the central nervous system4
Monkeypox virus replication underlying circadian rhythm networks4
Stroke risk after varicella-zoster virus infection: a systematic review and meta-analysis4
Multi-functional auto-fluorescent nanogels for theranostics4
How an increase in the copy number of HSV-1 during latency can cause Alzheimer’s disease: the viral and cellular dynamics according to the microcompetition model4
Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice4
Higher buccal mitochondrial DNA and mitochondrial common deletion number are associated with markers of neurodegeneration and inflammation in cerebrospinal fluid4
Altered white matter microstructure and neurocognitive function of HIV-infected patients with low nadir CD44
Improved neurocognitive performance in FIV infected cats following treatment with the p75 neurotrophin receptor ligand LM11A-313
Associations of alcohol use, HIV infection, and age with brain white matter microstructure3
Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies3
Post-COVID-19 olfactory dysfunction: carbamazepine as a treatment option in a series of cases3
A comprehensive data-driven analysis framework for detecting impairments in brain function networks with resting state fMRI in HIV-infected individuals on cART3
A fulminant case of Epstein-Barr Virus encephalitis with multiorgan dysfunction3
Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study3
Nanoparticles and nanoformulated drugs as promising delivery system in treatment of microbial-induced CNS infection: a systematic review of literature3
Longitudinal telomere length profile does not reflect HIV and childhood trauma impacts on cognitive function in South African women3
Progressive multifocal leukoencephalopathy, advanced ductal breast carcinoma, systemic sclerosis, and checkpoint inhibitors: a therapeutic dilemma3
Acute vestibular neuritis: A rare complication after the adenoviral vector-based COVID-19 vaccine3
Altered expression of fractalkine in HIV-1-infected astrocytes and consequences for the virus-related neurotoxicity3
Assessment, prevalence, and correlates of frailty among middle-aged adults with HIV in rural Uganda3
Plasma anti-CD4 IgG is associated with brain abnormalities in people with HIV on antiretroviral therapy3
Relationship of the balloon analog risk task to neurocognitive impairment differs by HIV serostatus and history of major depressive disorder3
Cognitive deficits in HTLV-1 patients3
Main lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in HIV-1 subtypes C and B3
Disruption of blood–brain barrier: effects of HIV Tat on brain microvascular endothelial cells and tight junction proteins3
A unique case of Miller Fisher-Guillain-Barré overlap syndrome in a liver transplant recipient3
Seropositivity and reactivations of HSV-1, but not of HSV-2 nor VZV, associate with altered blood–brain barrier, beta amyloid, and tau proteins in people living with HIV3
Extensive longitudinal myelitis due to cytomegalovirus infection3
Cognitive screening in HTLV-1–infected people using a self-perceived memory score and auditory P3003
Encephalomyelitis in a patient with monkeypox: an unusual complication3
Neurological soft signs and brain morphology in people living with HIV3
SARS-CoV and SARS-CoV-2 display limited neuronal infection and lack the ability to transmit within synaptically connected axons in stem cell–derived human neurons3
Dengue fever presenting as acute cerebellar ataxia: Case report and literature review3
Mitochondrial DNA haplogroups and domain-specific neurocognitive performance in adults with HIV3
Central nervous system reactivation of herpesviridae family in patients with COVID-193
MicroRNA expression profiling of cerebrospinal fluid/serum exosomes in children with human herpesvirus 6-associated encephalitis/encephalopathy by high-throughput sequencing3
Influenza vaccination status in multiple sclerosis patients from Latin America3
Transcriptional signatures of Zika virus infection in astrocytes3
Systematic post-mortem analysis of brain tissue from an HIV-1 subtype C viremic decedent revealed a paucity of infection and pathology3
The prevalence and outcomes of depression in older HIV-positive adults in Northern Tanzania: a longitudinal study3
Risk factors for neurological complications in children with Flavivirus infection3
Clinical use of steroids in viral central nervous system (CNS) infections: three challenging cases3
Neuropsychological profile of patients with infectious disease: characterization and comparison of patients with HIV, HTLV, and HCV3
Zika virus infection of retinal cells and the developing mouse eye induces host responses that contrasts to the brain and dengue virus infection2
Risk factors of herpes simplex virus reactivation after surgery for primary trigeminal neuralgia2
Reduced neuronal population in the dorsolateral prefrontal cortex in infant macaques infected with simian immunodeficiency virus (SIV)2
Evolving etiologies, comorbidities, survival, and costs of care in adult encephalitis2
Components of metabolic syndrome associated with lower neurocognitive performance in youth with perinatally acquired HIV and youth who are HIV-exposed uninfected2
Pre-clinical atherosclerosis is found at post-mortem, in the brains of men with HIV2
Single nucleotide polymorphisms in aquaporin-4 associate with cognitive impairment status in people with HIV2
T-lymphocyte activation markers in patients with HIV-1-associated neurocognitive disorder2
HIV-1 and methamphetamine alter galectins -1, -3, and -9 in human monocyte-derived macrophages2
Characteristics of taste dysfunction in COVID-19 subjects coming from two different countries2
HIV peripheral neuropathy‐related degeneration of white matter tracts to sensorimotor cortex2
Longitudinal, virological, and serological assessment of hospitalized COVID-19 patients2
Successful treatment of HIV-associated progressive multifocal leukoencephalopathy (PML) with mirtazapine, mefloquine, and IVIG combination therapy: a case report2
Meningitis associated with HHV-7 in an Iranian immunocompetent adolescent girl2
A case-based systematic review on the SARS-COVID-2-associated cerebrovascular diseases and the possible virus routes of entry2
HIV-1 subtype B Tat enhances NOTCH3 signaling in astrocytes to mediate oxidative stress, inflammatory response, and neuronal apoptosis2
Herpesviruses, polyomaviruses, parvoviruses, papillomaviruses, and anelloviruses in vestibular schwannoma2
Interaction of declined handgrip strength and HIV infection on neurocognitive impairment2
Persistent accelerated epigenetic ageing in a longitudinal cohort of vertically infected HIV-positive adolescents2
Detection of disease-associated microglia among various microglia phenotypes induced by West Nile virus infection in mice2
A case of progressive multifocal leukoencephalopathy with hypogammaglobulinemia and a TCF3 mutation2
Serum of COVID-19 patients changes neuroinflammation and mitochondrial homeostasis markers in hippocampus of aged rats2
Undetectable JC virus CSF PCR in patients with JC virus-induced progressive multifocal leukoencephalopathy2
Using plasma proteomics to investigate viral infections of the central nervous system including patients with HIV-associated neurocognitive disorders2
Varicella zoster virus infection in neurological patients in Bulgaria2
Predictive factors of human cytomegalovirus reactivation in newly diagnosed glioblastoma patients treated with chemoradiotherapy2
Does antiretroviral therapy alter the course of Parkinson’s disease in people living with HIV?2
Neurological complications of COVID-19 in pediatric patients require comprehensive evaluation2
Atypical anti-NMDA receptor encephalitis associated with varicella zoster virus infection2
Sex-specific effects of low-dose hydrocortisone on threat detection in HIV2
Cytomegalovirus optic neuropathy in a young immunocompetent patient2
Meta-analysis of the serum/plasma proteome identifies significant associations between COVID-19 with Alzheimer’s/Parkinson’s diseases2
Plasma extracellular vesicles and cell-free mitochondrial DNA are associated with cognitive dysfunction in treated older adults with HIV2
Elevated Galectin-9 across the human brain correlates with HIV neuropathology and detrimental cognitive states2
Long-term sequelae of herpes simplex virus encephalitis–related white matter injury: correlation of neuropsychological outcome and diffusion tensor imaging2
Effects of unhealthy alcohol use on brain morphometry and neurocognitive function among people with HIV2
Microglia proliferation underlies synaptic dysfunction in the prefrontal cortex: implications for the pathogenesis of HIV-1-associated neurocognitive and affective alterations2
Effects of cocaine and HIV on decision-making abilities2
0.20709109306335